Alternatives to Genvoya If You Can't Fill Your Prescription

If you're unable to fill your Genvoya prescription — whether due to a stock issue, insurance problem, or high cost — your HIV provider may discuss switching you to an alternative medication. This is not a decision to make on your own, but understanding your options can help you have a more informed conversation with your care team.

Important: Never stop taking Genvoya or any HIV medication without talking to your provider first. Stopping abruptly can allow the virus to rebound, and if you have co-existing hepatitis B, stopping Genvoya can cause a dangerous flare-up of your hepatitis B infection.

What Makes a Good Genvoya Alternative?

Genvoya is a complete HIV regimen — one pill a day that covers all the antiretroviral activity you need. Any alternative your provider considers must also provide a complete, effective regimen tailored to your specific HIV history, resistance profile, other health conditions (especially kidney function and hepatitis B status), and other medications you take.

Biktarvy (Bictegravir/Emtricitabine/Tenofovir Alafenamide)

Biktarvy is the most commonly prescribed first-line HIV regimen in the U.S. today and is often considered Genvoya's closest real-world alternative. Like Genvoya, it is a once-daily single tablet containing emtricitabine and tenofovir alafenamide (TAF). The key difference: Biktarvy uses bictegravir as its integrase inhibitor and does not require a pharmacokinetic booster like cobicistat.

Because Biktarvy doesn't have a booster, it has fewer drug interactions than Genvoya. It's also approved for patients as young as those weighing 14 kg. Biktarvy is currently listed by the DHHS as a preferred first-line regimen for most adults.

Key consideration: Biktarvy has a high barrier to resistance, making it excellent for long-term treatment. It does not require food to be taken with, though food can help reduce nausea.

Dovato (Dolutegravir/Lamivudine)

Dovato is a two-drug regimen (dolutegravir + lamivudine) that has shown high efficacy in both treatment-naïve patients and those switching from a suppressed regimen. It has an excellent safety profile and fewer pills than older regimens. However, Dovato is not appropriate for patients with hepatitis B co-infection (since it lacks tenofovir, which also treats HBV) or those with pre-treatment HIV RNA above 500,000 copies/mL.

Key consideration: Your provider will test for hepatitis B before considering Dovato. It also has a potential risk of neural tube defects if taken during the first trimester of pregnancy.

Triumeq (Dolutegravir/Abacavir/Lamivudine)

Triumeq is a three-drug once-daily tablet containing dolutegravir, abacavir, and lamivudine. It's been a mainstay of HIV treatment for years and has strong efficacy and tolerability. The major caveat: it requires HLA-B*5701 genetic testing before use, because patients who carry this gene variant are at risk for a serious hypersensitivity reaction to abacavir. Like Dovato, it is not suitable for hepatitis B co-infection.

Key consideration: Requires genetic testing before starting. Widely available at most pharmacies, which can be an advantage when Genvoya is unavailable.

Symtuza (Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide)

Symtuza is a four-drug, once-daily tablet that also contains cobicistat and emtricitabine/tenofovir alafenamide — two of the same drugs in Genvoya. Instead of elvitegravir, it uses darunavir, a protease inhibitor. It must be taken with food, just like Genvoya. Symtuza may be considered when a protease inhibitor-based regimen is preferred or when integrase inhibitor resistance is present.

Cabenuva (Cabotegravir/Rilpivirine) — The Injectable Option

For patients who are virologically suppressed and want to eliminate daily pills entirely, Cabenuva offers a long-acting injectable regimen administered by a healthcare provider once a month (or once every two months). While not a direct Genvoya replacement for everyone, it's an option worth discussing if you're frustrated with pill access challenges.

How to Talk to Your Doctor About Switching

If you're considering a switch due to access challenges, come to your appointment prepared to discuss:

Your current viral load and CD4 count

Your hepatitis B status

Your kidney function (eGFR/creatinine clearance)

All other medications you take (especially for interactions with cobicistat)

Whether pregnancy is a possibility (relevant for dolutegravir-containing regimens)

Try medfinder Before Switching

Before committing to a medication switch, it's worth trying to locate Genvoya in stock near you. medfinder calls pharmacies on your behalf to find which ones can fill your Genvoya prescription. This can save you the disruption of switching regimens when the problem is simply a local stock issue rather than a true unavailability.

Read more about why Genvoya can be hard to find before deciding your next step.